Table Angiorus n / v + 50mg 450mg film 60 pcs

Description

Composition
Active substance:
1 tablet contains: hesperidin – 50 mg, diosmin – 450 mg.
Excipients:
Hypromellose (oksimetilpropiltsellyuloza) – 6.5 mg, lactose monohydrate (milk sugar) – 42 mg talc – 22.8 mg Magnesium stearate – 7.6 mg Sodium carboxymethyl starch (sodium starch glycolate) – 22.8 mg Microcrystalline cellulose – 158.3 mg. shell composition: Opadry II yellow – 22.8 mg. Ingredients Opadry II yellow: Macrogol 4000 (polyethylene glycol 4000) – 4.6056 mg of titanium dioxide – 1.6188 mg talc – 3.3744 mg, polyvinylalcohol – 9.1200 mg Iron oxide yellow dye – 4.0812 mg.
Description:
Oval biconvex tablets, film-coated yellow-brown color. Kind of pills on a break – from light yellow to grayish-yellow color.
Product form:
Film-coated tablets 50 mg + 450 mg. 10 tablets in blisters of PVC film and aluminum foil printed patent. 20, 30, 60 tablets in a polymeric jars. Each jar 2, 3, 6, the contour of cellular packages with instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity, breastfeeding. Patients with a rare hereditary diseases such as galactose intolerance, lactase deficiency syndrome or glucose-galactose malabsorption.
Dosage
50 mg + 450 mg
Indications
Therapy symptoms venous-lymphatic insufficiency: pain; lower limbs cramp; a feeling of heaviness and fullness in the legs; “Tired” legs.
Therapy manifestations of venous-lymphatic insufficiency: edema of the lower extremities; trophic changes in the skin and subcutaneous tissue; venous trophic ulcers.
Symptomatic treatment of acute and chronic hemorrhoids.
Interaction with other drugs
Data on the interaction with other drugs are not available.
It is necessary to inform the doctor about all the medicines you are taking.
Overdose
Data on overdose are not available.
pharmachologic effect
Pharmacological group:
Venotoniziruschee means.
Pharmacodynamics:
It has angioproteguoe and venotonic properties. The drug reduces the extensibility of the veins and venous stasis, reduces capillary permeability and increases their resistance, improve microcirculation and lymph flow. The systematic use reduces the severity of the clinical manifestations of chronic venous insufficiency of the lower limbs and functional organic nature.
Pharmacokinetics:
Basic elimination of the drug takes place through the intestines. Kidneys average output of about 14% of the received amount of the drug. half-life is 11 hours. The drug undergoes active metabolism, which is confirmed by the presence of phenolic acids in the urine.
Pregnancy and breast-feeding
Animal experiments did not reveal any teratogenic effects. Until now there has been no reports of adverse effects when using the drug in pregnant women. Due to lack of data on the excretion of the drug in breast milk is not recommended taking the drug during breastfeeding. Reproductive toxicity studies have not shown effects on reproductive function in rats of both sexes.
Conditions of supply of pharmacies
Without recipe.
side effects
The incidence of adverse reactions is given in accordance with the WHO classifications: very often (> 1/10); common (> 1/100,
special instructions
Before you start taking the drug ANGIORUS recommended to consult a doctor. During exacerbation of hemorrhoids ANGIORUS use of the drug does not replace specific treatment other anal disorders. The duration of treatment should not exceed the time specified in the “Method of administration and dose.” In that case, if the symptoms do not disappear after the recommended course of therapy, proctology examination should be conducted and review applied therapy. In the presence of venous circulation disorders maximum treatment effect provided by a combination therapy with a healthy (balanced) manner life is desirable to avoid a long stay in the sun, prolonged standing, and is also recommended reduction of overweight. Hiking and, in some cases, wearing special stockings that improve blood circulation. Immediately contact your doctor if you are in the process of treating your condition worse or no improvement. Effects on ability to drive vehicles and mechanisms: No effect.
Storage conditions
Store in a dark place at a temperature not higher than 30 ° C. Keep out of the reach of children.
Dosing and Administration
Inside, during a meal.
If veno-lymphatic insufficiency – 2 tablets per day (one or two doses): morning, afternoon and / or evening.
The duration of treatment may last several months (up to 12 months).
In the case of recurrence of symptoms, on doctor’s advice, treatment can be repeated.
In acute hemorrhoid – 6 tablets per day: 3 tablets morning and evening for 3 tablets for 4 days, then 4 tablets per day: 2 tablets in the morning and 2 tablets in the evening over the next 3 days.
The recommended dose for chronic hemorrhoids – 2 tablets per day.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist